The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $113.35

Today's change+0.66 +0.59%
Updated May 25 4:00 PM EDT. Delayed by at least 15 minutes.
 

Johnson & Johnson

NYSE: JNJ
Last

(U.S.) $113.35

Today's change+0.66 +0.59%
Updated May 25 4:00 PM EDT. Delayed by at least 15 minutes.

Johnson & Johnson crosses above 20-day moving average

Johnson & Johnson closed up Wednesday by (U.S.)$0.66 or 0.59% to (U.S.)$113.35 and crossing above its 20-day moving average. Over the last five days, shares are unchanged, but are currently 1.43% below its 52-week high. This security has outperformed the S&P 500 by 13.51% during the last year.

Key company metrics

  • Open(U.S.) $113.18
  • Previous close(U.S.) $112.69
  • High(U.S.) $113.73
  • Low(U.S.) $112.85
  • Bid / Ask-- / --
  • YTD % change+10.35%
  • Volume5,455,518
  • Average volume (10-day)7,095,640
  • Average volume (1-month)6,990,951
  • Average volume (3-month)8,647,091
  • 52-week range(U.S.) $81.79 to (U.S.) $115.00
  • Beta0.59
  • Trailing P/E20.66×
  • P/E 1 year forward17.06×
  • Forward PEG2.85×
  • Indicated annual dividend(U.S.) $3.20
  • Dividend yield2.82%
  • Trailing EPS(U.S.) $5.49
Updated May 25 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.72%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 03, 201604/03/2016Jan 03, 201601/03/2016Sep 27, 201509/27/2015Jun 28, 201506/28/2015
Revenue17,48217,81117,10217,787
Total other revenue--------
Total revenue17,48217,81117,10217,787
Gross profit12,15312,13811,87812,430
Total cost of revenue5,3295,6735,2245,357
Total operating expense12,18814,05312,98012,046
Selling / general / administrative4,6885,8915,0815,384
Research & development2,0132,8642,1542,129
Depreciation / amortization--------
Interest expense (income), net operating160160123131
Unusual expense (income)120723100
Other operating expenses, total-34-1,205412-1,055
Operating income5,2943,7584,1225,741
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax5,2943,7584,1225,741
Income after tax4,2923,2153,3584,516
Income tax, total1,0025437641,225
Net income4,2923,2153,3584,516
Total adjustments to net income--------
Net income before extra. items4,2923,2153,3584,516
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items4,2923,2153,3584,516
Inc. avail. to common incl. extra. items4,2923,2153,3584,516
Diluted net income4,2923,2153,3584,516
Dilution adjustment----00
Diluted weighted average shares2,7952,8002,8072,812
Diluted EPS excluding extraordinary itemsvalue per share1.541.151.201.61
Dividends per sharevalue per share0.750.750.750.75
Diluted normalized EPSvalue per share1.501.571.201.61